Profiel
Karl Whitney is Senior Vice President-Global Regulatory Affairs at Passage Bio, Inc. since 2024.
Dr. Whitney is Co-President at International Foxp1 Foundation since 2021.
Formerly, Dr. Whitney was Vice President & Head-Regulatory Affairs at Precision BioSciences, Inc. from 2020 to 2024.
Dr. Whitney was Principal at Rho, Inc. Education includes undergraduate studies at Yale University and a doctorate from Duke University.
Actieve functies van Karl Whitney
| Bedrijven | Functie | Begin |
|---|---|---|
| PASSAGE BIO, INC. | Algemeen Adviseur | 01-02-2024 |
Eerdere bekende functies van Karl Whitney
| Bedrijven | Functie | Einde |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Algemeen Adviseur | 01-01-2024 |
Rho, Inc.
Rho, Inc. Miscellaneous Commercial ServicesCommercial Services Provides collection processing and management of clinical research | Corporate Officer/Principal | - |
Opleiding van Karl Whitney
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rho, Inc.
Rho, Inc. Miscellaneous Commercial ServicesCommercial Services Provides collection processing and management of clinical research | Commercial Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
















